INmune Bio(INMB) - 2022 Q1 - Earnings Call Transcript

INmune Bio, Inc. (NASDAQ:INMB) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants David Moss – Co-Founder and Chief Financial Officer RJ Tesi – Chairman and Chief Executive Officer CJ Barnum – Head of Neuroscience Conference Call Participants William Wood – B. Riley Securities Matthew Cross – Alliance Global Partners Sung Hong – BTIG Daniel Carlson – TW Research Group Operator Greetings, and welcome to the INmune Bio First Quarter 2022 Earnings Call. At this time, all participants ...